About Kallyope
Kallyope is a company based in New York (United States) founded in 2014 by Charles Zuker, Richard Axel, and Tom Maniatis.. Kallyope has raised $479 million across 6 funding rounds from investors including Illumina, ARE and StepStone Group. The company has 84 employees as of December 31, 2021. Kallyope offers products and services including Klarity Platform. Kallyope operates in a competitive market with competitors including Evelo Biosciences, Synlogic Therapeutics, Trace Genomics, PathogenDX and Manus Bio, among others.
- Headquarter New York, United States
- Employees 84 as on 31 Dec, 2021
- Founders Charles Zuker, Richard Axel, Tom Maniatis
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kallyope Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$479 M (USD)
in 6 rounds
-
Latest Funding Round
$8.2 M (USD), Grant
May 10, 2023
-
Investors
Illumina
& 20 more
-
Employee Count
84
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kallyope
Kallyope offers a comprehensive portfolio of products and services, including Klarity Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology for discovering therapeutics in metabolic and neurological fields.
Unlock access to complete
Unlock access to complete
Funding Insights of Kallyope
Kallyope has successfully raised a total of $479M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $8.2 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $8.2M
-
First Round
First Round
(10 Dec 2015)
- Investors Count 21
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Grant - Kallyope | Valuation |
investors |
|
| Feb, 2022 | Amount | Series D - Kallyope | Valuation | Mubadala , TCG | |
| Mar, 2020 | Amount | Series C - Kallyope | Valuation | Illumina Ventures , Alexandria |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kallyope
Kallyope has secured backing from 21 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Illumina, ARE and StepStone Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage technology companies are funded by Lux Capital.
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
Early-stage investments in US life science startups are focused on.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kallyope
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Kallyope
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kallyope Comparisons
Competitors of Kallyope
Kallyope operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evelo Biosciences, Synlogic Therapeutics, Trace Genomics, PathogenDX and Manus Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
|
|
| domain | founded_year | HQ Location |
Engineered microbes are developed as programmable therapeutics for metabolic disorders.
|
|
| domain | founded_year | HQ Location |
Developer of technologies to diagnose soil health and soil-borne disease prediction
|
|
| domain | founded_year | HQ Location |
Provider of DNA-based pathogen testing kits
|
|
| domain | founded_year | HQ Location |
Phytochemicals are developed using microbial fermentation processes.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kallyope
Frequently Asked Questions about Kallyope
When was Kallyope founded?
Kallyope was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Kallyope located?
Kallyope is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of Kallyope?
Jay Galeota is the current CEO of Kallyope.
Is Kallyope a funded company?
Kallyope is a funded company, having raised a total of $479M across 6 funding rounds to date. The company's 1st funding round was a Series C of $112M, raised on Dec 10, 2015.
How many employees does Kallyope have?
As of Dec 31, 2021, the latest employee count at Kallyope is 84.
What does Kallyope do?
Kallyope was founded in 2014 in New York, United States, as a biotechnology platform focused on the gut-brain axis. Technologies in sequencing, bioinformatics, neural imaging, cellular and molecular biology, and human genetics are integrated to study interactions between the brain and gut microbes. This approach is applied to identify microbiome-derived molecules that influence human behavior, leading to the development of therapeutics and nutritional products for health improvement.
Who are the top competitors of Kallyope?
Kallyope's top competitors include PathogenDX, Trace Genomics and Azitra.
What products or services does Kallyope offer?
Kallyope offers Klarity Platform.
Who are Kallyope's investors?
Kallyope has 21 investors. Key investors include Illumina, ARE, StepStone Group, Gates Foundation, and Mubadala.